Epigenetic phenomena linked to diabetic complications

[1]  M. Prentki,et al.  Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells. , 2010, Endocrinology.

[2]  A. Riggs,et al.  Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation* , 2009, Journal of Biological Chemistry.

[3]  A. Stadlmayr,et al.  A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  A. Rissanen,et al.  Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[5]  Reid F. Thompson,et al.  Experimental Intrauterine Growth Restriction Induces Alterations in DNA Methylation and Gene Expression in Pancreatic Islets of Rats* , 2010, The Journal of Biological Chemistry.

[6]  J. Albers,et al.  Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.

[7]  Reid F. Thompson,et al.  Cytosine Methylation Dysregulation in Neonates Following Intrauterine Growth Restriction , 2010, PloS one.

[8]  S. Chakrabarti,et al.  Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. , 2010, American journal of physiology. Endocrinology and metabolism.

[9]  L. Groop,et al.  Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes , 2009, Diabetes.

[10]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[11]  D. Baltimore,et al.  Regulation of NF-κB activity through lysine monomethylation of p65 , 2009, Proceedings of the National Academy of Sciences.

[12]  G. Gill,et al.  SUMO engages multiple corepressors to regulate chromatin structure and transcription , 2009, Epigenetics.

[13]  P. Park.  ChIP–seq: advantages and challenges of a maturing technology , 2009, Nature Reviews Genetics.

[14]  P. Casanello,et al.  Epigenetics: new concepts of old phenomena in vascular physiology. , 2009, Current vascular pharmacology.

[15]  S. Jacobsen,et al.  SET7/9 mediated methylation of non-histone proteins in mammalian cells , 2009, Epigenetics.

[16]  D. Giugliano,et al.  Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  B. Zinman,et al.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). , 2009, Archives of internal medicine.

[18]  D. Kabra,et al.  Insulin induced alteration in post-translational modifications of histone H3 under a hyperglycemic condition in L6 skeletal muscle myoblasts. , 2009, Biochimica et biophysica acta.

[19]  S. Jacobsen,et al.  Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells , 2009, Proceedings of the National Academy of Sciences.

[20]  M. Ihnat,et al.  Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? , 2009, The Journal of clinical endocrinology and metabolism.

[21]  B. Maier,et al.  Methyltransferase Set7/9 Maintains Transcription and Euchromatin Structure at Islet-Enriched Genes , 2009, Diabetes.

[22]  M. Cooper,et al.  Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail , 2008, Diabetes.

[23]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[24]  S. Schinner,et al.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[25]  Brian C. Smith,et al.  Chemical mechanisms of histone lysine and arginine modifications. , 2009, Biochimica et biophysica acta.

[26]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[27]  E. Li,et al.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation , 2009, Nature Genetics.

[28]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[29]  A. Cecile J.W. Janssens,et al.  Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies , 2008, Diabetes.

[30]  M. Cooper,et al.  UKPDS and the legacy effect. , 2008, The New England journal of medicine.

[31]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[32]  R. Roeder,et al.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.

[33]  B. Ren,et al.  Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes , 2008, Journal of Biological Chemistry.

[34]  J. Mourad,et al.  Contrôle tensionnel, facteurs de risque et pronostic cardiovasculaire du patient diabétique: 30 ans de progrès , 2008 .

[35]  J. Mourad,et al.  Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. , 2008, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[36]  L. Lanting,et al.  Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes , 2008, Proceedings of the National Academy of Sciences.

[37]  M. Ihnat,et al.  Evaluation of gliclazide ability to attenuate the hyperglycaemic ‘memory’ induced by high glucose in isolated human endothelial cells , 2008, Diabetes/metabolism research and reviews.

[38]  Sybille Bergmann,et al.  Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany , 2008, Diabetes Care.

[39]  Vikki M. Weake,et al.  Histone ubiquitination: triggering gene activity. , 2008, Molecular cell.

[40]  J. Shaw,et al.  Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies , 2008, The Lancet.

[41]  Dustin E. Schones,et al.  Genome-wide approaches to studying chromatin modifications , 2008, Nature Reviews Genetics.

[42]  Hong Lei,et al.  Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. , 2008, Molecular cell.

[43]  A. Bhalla,et al.  Images in clinical medicine. Paget's disease of the mandible. , 2008, The New England journal of medicine.

[44]  T. Tollefsbol,et al.  Gene-environment interactions and epigenetic basis of human diseases. , 2008, Current issues in molecular biology.

[45]  C. Szabó,et al.  Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling , 2007, Diabetologia.

[46]  S. Bornstein,et al.  Development of a Diabetes Prevention Management Program for Clinical Practice , 2007, Public health reports.

[47]  M. Cooper,et al.  Diabetic nephropathy: where hemodynamics meets metabolism. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[48]  C. Allis,et al.  Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. , 2007, Molecular cell.

[49]  Woojin An,et al.  Histone acetylation and methylation: combinatorial players for transcriptional regulation. , 2007, Sub-cellular biochemistry.

[50]  L. Guarente.  Sirtuins as potential targets for metabolic syndrome , 2006, Nature.

[51]  A. Flyvbjerg,et al.  Prevention and early detection of vascular complications of diabetes , 2006, BMJ : British Medical Journal.

[52]  L. Lanting,et al.  Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. , 2006, Molecular endocrinology.

[53]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[54]  P. De Meyts,et al.  Role of histone and transcription factor acetylation in diabetes pathogenesis , 2005, Diabetes/metabolism research and reviews.

[55]  Kevin Struhl,et al.  Intrinsic histone-DNA interactions and low nucleosome density are important for preferential accessibility of promoter regions in yeast. , 2005, Molecular cell.

[56]  A. Mosley,et al.  The Pancreatic Duodenal Homeobox-1 Protein (Pdx-1) Interacts with Histone Deacetylases Hdac-1 and Hdac-2 on Low Levels of Glucose* , 2004, Journal of Biological Chemistry.

[57]  A. Mosley,et al.  Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. , 2004, Molecular endocrinology.

[58]  Rama Natarajan,et al.  In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions* , 2004, Journal of Biological Chemistry.

[59]  K. Garber.  Purchase of Aton spotlights HDAC inhibitors , 2004, Nature Biotechnology.

[60]  Victor G Corces,et al.  Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.

[61]  K. Xiang,et al.  Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. , 2004, Diabetes.

[62]  Irene M. Stratton,et al.  UK prospective diabetes study (UKPDS) , 2004, Diabetologia.

[63]  A. El-Osta.  DNMT cooperativity—the developing links between methylation, chromatin structure and cancer , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[64]  R. Eisenman,et al.  Histone sumoylation is associated with transcriptional repression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Mosley,et al.  Glucose Regulates Insulin Gene Transcription by Hyperacetylation of Histone H4* , 2003, Journal of Biological Chemistry.

[66]  E. Strengman,et al.  A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13. , 2003, The Journal of clinical endocrinology and metabolism.

[67]  R. Kowluru.  Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. , 2003, Diabetes.

[68]  G. King,et al.  Molecular understanding of hyperglycemia's adverse effects for diabetic complications. , 2002, JAMA.

[69]  B. Turner,et al.  Cellular Memory and the Histone Code , 2002, Cell.

[70]  H. Grossniklaus.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Writing Team ∗ for the Diabetes Control and Complications Trial/Epidemiol-ogy of Diabetes Interventions and Complications Research Group. JAMA 2002;287:2563-2569. , 2002 .

[71]  S. Maier,et al.  Diabetes: a candidate disease for efficient DNA methylation profiling. , 2002, The Journal of nutrition.

[72]  M. McCarthy,et al.  Genetic approaches to the molecular understanding of type 2 diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[73]  Kevin Struhl,et al.  Methylation of H3-Lysine 79 Is Mediated by a New Family of HMTases without a SET Domain , 2002, Current Biology.

[74]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[75]  D. Reinberg,et al.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. , 2002, Genes & development.

[76]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[77]  Hengbin Wang,et al.  Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. , 2001, Molecular cell.

[78]  L. Poirier,et al.  Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. , 2001, Metabolism: clinical and experimental.

[79]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[80]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[81]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[82]  A. Wolffe,et al.  Acetylation of general transcription factors by histone acetyltransferases , 1997, Current Biology.

[83]  Renato Paro,et al.  Mapping polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin , 1993, Cell.

[84]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[85]  H. Hammes,et al.  Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. , 1993, Investigative ophthalmology & visual science.

[86]  E. Cagliero,et al.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[87]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.